December 2026
1. JIN Y, Song T, Jiang T, Wei Y, et al
   FUNDC2 contributes to hypertensive vascular remodeling by regulating mitochondrial dynamics and ferroptosis in perivascular adipose tissue.
   Clin Exp Hypertens. 2026;48:2610587.
   

   >> Share

   
   
2. ZHAO M, Liu Q, Shi NJ, Li Y, et al
   Gut microbiota and hypertension: role of exercise training.
   Clin Exp Hypertens. 2026;48:2608905.
   

   >> Share

   
   
3. JIANJUN Y
   Bilateral hypertensive retinopathy (grade 4): Case report and review of the literature on intravitreal injection anti-VEGF therapy.
   Clin Exp Hypertens. 2026;48:2604831.
   

   >> Share

   
   
4. ZHOU Z, Fang Q, Li X, Li C, et al
   Arachidonic acid intake promotes hypertension and target-organ fibrosis through CYP4A-mediated 20-HETE overproduction: Integrated evidence from human and animal studies.
   Clin Exp Hypertens. 2026;48:2611130.
   

   >> Share

   
   
5. WANG MJ, Chen CP, Chiu NF, Sun FJ, et al
   Longitudinal trajectory of circulating microRNA-210-3p and its association with low-dose aspirin use in gestational hypertension and preeclampsia: a pilot study.
   Clin Exp Hypertens. 2026;48:2616534.
   

   >> Share

   
   
6. ZEHIR R, Dogan C, Avci A, Alici G, et al
   Assessment of the safety and effectiveness of catheter-based renal denervation with the symplicity spyral system in patients with resistant hypertension: A single-center experience.
   Clin Exp Hypertens. 2026;48:2617997.
   

   >> Share

   
   
7. ESKI S, Taskan H, Allahverdiyev S, Yasar S, et al
   Association of carotid body size with left atrial strain and peripheral hemodynamics in patients with hypertension: An exploratory study.
   Clin Exp Hypertens. 2026;48:2621676.
   

   >> Share

   
   
8. FAN L, Zhou Z, Zhao S, Zhong Z, et al
   Relationship between kidney length and renal risk in malignant hypertension patients with renal thrombotic microangiopathy.
   Clin Exp Hypertens. 2026;48:2617514.
   

   >> Share

   
   December 2025
9. SU Y, Zhang M, Xu P, Wen P, et al
   Genetic causal assessment between major depression and hypertension: A two-sample bidirectional Mendelian randomization study.
   Clin Exp Hypertens. 2025;47:2553507.
   

   >> Share

   
   
10. SUN Z, Dai G, Quan N
    Hypertension accelerates aging: Evidence from NHANES database and Mendelian randomization analyses.
    Clin Exp Hypertens. 2025;47:2559743.
    

    >> Share

    
    
11. JIANG G, Li X, Fang Z, Shi G, et al
    miPEP31 inhibits the vascular smooth muscle cell proliferation via cooperation with transcription factor Trps1.
    Clin Exp Hypertens. 2025;47:2561235.
    

    >> Share

    
    
12. ZHOU J, Su Y, He L, Ding N, et al
    Association of different diet quality scores with cardiovascular disease mortality risk in hypertension treatment group.
    Clin Exp Hypertens. 2025;47:2563779.
    

    >> Share

    
    
13. CHEN L, Wang X, Luo L, Li Y, et al
    The effect of comprehensive intervention on children with anxiety/depression and increased blood pressure.
    Clin Exp Hypertens. 2025;47:2560635.
    

    >> Share

    
    
14. TIAN X, Zou Y, Zhou Y, Zhang Y, et al
    Investigating non-invasive hemodynamic indicators in hypertension patients with coronary atherosclerotic heart disease.
    Clin Exp Hypertens. 2025;47:2564296.
    

    >> Share

    
    
15. SONG H, Li J, Lan L, Meng H, et al
    The causal relationship between aspartate aminotransferase and hypertension: A bidirectional Mendelian randomization study.
    Clin Exp Hypertens. 2025;47:2564298.
    

    >> Share

    
    
16. WU J, Zhu X, Wu Q, Xiao F, et al
    Interdisciplinary collaborative care model combined with family empowerment in patients with comorbid hypertension and diabetes: A study on blood pressure/glucose control and psychosocial adaptation based on the COM-B model.
    Clin Exp Hypertens. 2025;47:2570212.
    

    >> Share

    
    
17. GU D, Chen M, Yang Y, Lu C, et al
    Targeting the PHD2/HIF-1alpha/HO-1 pathway: A key role of trimetazidine in hypertensive nephropathy.
    Clin Exp Hypertens. 2025;47:2563033.
    

    >> Share

    
    
18. GUO F, Qin L, Chen B, Xu H, et al
    Predictive model combining blood pressure, glycemic and renal markers for diabetic nephropathy in elderly hypertensive patients with type 2 diabetes.
    Clin Exp Hypertens. 2025;47:2564299.
    

    >> Share

    
    
19. YE B, Su D, Huang Y, Liu D, et al
    Interaction of circPcmtd1 with HSP90AB1 mediates phosphorylation of AKT to regulate pulmonary arterial hypertension induced by high pulmonary blood flow in rat.
    Clin Exp Hypertens. 2025;47:2583193.
    

    >> Share

    
    
20. ZHANG S, Tang M, Wu Q, Tan H, et al
    Transcatheter hybrid closure of a large muscular ventricular septal defect with severe pulmonary hypertension using a duct occluder.
    Clin Exp Hypertens. 2025;47:2586068.
    

    >> Share

    
    
21. XU C, Li Z, Zeng Y, Luo H, et al
    Gastrin signaling in cardiovascular pathophysiology: From molecular crosstalk to clinical implications.
    Clin Exp Hypertens. 2025;47:2584566.
    

    >> Share

    
    
22. ZHENG Q, Zhao Z, Wang L, Yu C, et al
    Identification of endoplasmic reticulum stress-associated signatures of human pulmonary arterial hypertension: A bioinformatic analysis.
    Clin Exp Hypertens. 2025;47:2584570.
    

    >> Share

    
    
23. LUO R, Huang Y, Leng Y, Liao W, et al
    Blood pressure variability: From predictive marker to intervention target-breaking the vicious cycle of hypertensive target organ damage.
    Clin Exp Hypertens. 2025;47:2601054.
    

    >> Share

    
    
24. ZHENG J, Lu C
    Metabolic dysfunction-associated fatty liver disease and risk of hypertension in young adults: A cross-sectional study mediated by inflammatory markers.
    Clin Exp Hypertens. 2025;47:2597852.
    

    >> Share

    
    
25. WEI X, Li L, Zhao G, Luan Y, et al
    Hypertension and Alzheimer's disease: Pathological interplay, comorbidity risks, and new strategies for synergistic management.
    Clin Exp Hypertens. 2025;47:2595154.
    

    >> Share

    
    
26. TANAKA M, Akiyama Y, Mori K, Hosaka I, et al
    Machine learning-based analyses of contributing factors for the development of hypertension: a comparative study.
    Clin Exp Hypertens. 2025;47:2449613.
    

    >> Share

    
    
27. ZHANG K, Deng X, Li Z, Yi C, et al
    Effect of oral potassium supplementation on urinary potassium excretion and its diagnostic value for primary aldosteronism.
    Clin Exp Hypertens. 2025;47:2457768.
    

    >> Share

    
    
28. YANG H, Xing H, Zou X, Jin M, et al
    Efficacy and safety of intensive blood pressure control in patients over 60 years: A systematic review and meta-analysis.
    Clin Exp Hypertens. 2025;47:2465399.
    

    >> Share

    
    
29. HAN JH, Sharapatov Y, Do MT, Kim SY, et al
    Safety and efficacy of extravascular renal denervation using HyperQure renal denervation system in short-term swine model of hypertension.
    Clin Exp Hypertens. 2025;47:2474520.
    

    >> Share

    
    
30. ZHANG J, Zhang W, Yang Z, Fan B, et al
    Cinnamaldehyde alleviates pulmonary hypertension by affecting vascular remodeling through the TLR4/NF-kB/HIF-1a pathway.
    Clin Exp Hypertens. 2025;47:2486829.
    

    >> Share

    
    
31. HUANG Y, Li Z, Zhu J, Xiao L, et al
    Construction of a risk prediction model for adverse pregnancy outcomes in primipara with gestational diabetes mellitus combined with pregnancy-induced hypertension syndrome.
    Clin Exp Hypertens. 2025;47:2492621.
    

    >> Share

    
    
32. WU D, Xiong J, Huang Y, Yuan Y, et al
    Establishment of a lupus-prone mouse model of pulmonary arterial hypertension with intermittent hypoxia: functional, biochemical and histological verifications.
    Clin Exp Hypertens. 2025;47:2500383.
    

    >> Share

    
    
33. XU J, Zhao J, Gu J, Wang W, et al
    Serum uric acid levels as a causal factor in hypertension: Insights from Mendelian randomization analysis.
    Clin Exp Hypertens. 2025;47:2496514.
    

    >> Share

    
    
34. LIU X, Tan X, Su Y, Zou L, et al
    Anthocyanin attenuates pulmonary arterial hypertension and associated heart failure via improving mitochondrial function through Nrf2-dependent mechanism.
    Clin Exp Hypertens. 2025;47:2503805.
    

    >> Share

    
    
35. GUO S, Su Y, Li Y, Li C, et al
    The causal relationship between circulating metabolites and gestational hypertension, pre-eclampsia, eclampsia: A bidirectional two-sample Mendelian randomization study.
    Clin Exp Hypertens. 2025;47:2508787.
    

    >> Share

    
    
36. YESILDAG M, Duksal F
    Comorbidities and anthropometric parameters in obstructive sleep apnea syndrome: a phenotype-based study.
    Clin Exp Hypertens. 2025;47:2512136.
    

    >> Share

    
    
37. XU Y, Deng C, Liang X
    Parathyroid hormone and vitamin D modulate nocturnal blood pressure dipping: a retrospective cohort study in primary hypertension.
    Clin Exp Hypertens. 2025;47:2512130.
    

    >> Share

    
    
38. HUANG X, Hu W, Chen L, Ma L, et al
    Mechanistic study of the association between microRNA-126 and hypertension in obstructive sleep apnea-hypopnea syndrome.
    Clin Exp Hypertens. 2025;47:2511056.
    

    >> Share

    
    
39. BIRD GS, Lin YP, Tucker CJ, Mueller G, et al
    L-type calcium channel blockers at therapeutic concentrations are not linked to CRAC channels and heart failure.
    Clin Exp Hypertens. 2025;47:2515924.
    

    >> Share

    
    
40. CHEN X, Sun L, Xuan K, Zong A, et al
    The role of immune mechanisms in hypertension and advances in immunomodulatory research.
    Clin Exp Hypertens. 2025;47:2535328.
    

    >> Share

    
    December 2024
41. LAN C, Fang G, Qiu C, Li X, et al
    Inhibition of DYRK1A attenuates vascular remodeling in pulmonary arterial hypertension via suppressing STAT3/Pim-1/NFAT pathway.
    Clin Exp Hypertens. 2024;46:2297642.
    

    >> Share

    
    
42. SUN Y, Shang Q
    Research hotspots and trends regarding microRNAs in hypertension: a bibliometric analysis.
    Clin Exp Hypertens. 2024;46:2304017.
    

    >> Share

    
    
43. HE C, Li R, Yang J, Shen H, et al
    Optimizing the aldosterone-to-renin ratio cut-off for screening primary aldosteronism based on cardiovascular risk: a collaborative study.
    Clin Exp Hypertens. 2024;46:2301571.
    

    >> Share

    
    
44. YUAN Y, Shi J, Sun W, Kong X, et al
    The positive association between the atherogenic index of plasma and the risk of new-onset hypertension: a nationwide cohort study in China.
    Clin Exp Hypertens. 2024;46:2303999.
    

    >> Share

    
    
45. LIU Y, Lv Z, Zhou S, Fu Z, et al
    A smartwatch sphygmomanometer-based model for predicting short-term new-onset hypertension in individuals with high-normal blood pressure: a cohort study.
    Clin Exp Hypertens. 2024;46:2304023.
    

    >> Share

    
    
46. LU J, Li Z, Yang Y, Wei F, et al
    Chronic exercise improves renal AT(1) and ETB receptor functions via modulating GRK4 expression in obese Zucker rats.
    Clin Exp Hypertens. 2024;46:2323532.
    

    >> Share

    
    
47. DENG X, Luo H, He J, Deng W, et al
    Omentin-1 ameliorates pulmonary arterial hypertension by inhibiting endoplasmic reticulum stress through AMPKalpha signaling.
    Clin Exp Hypertens. 2024;46:2332695.
    

    >> Share

    
    
48. YANG C, Song Y, Wang P
    Relationship between triglyceride-glucose index and new-onset hypertension in general population-a systemic review and meta-analysis of cohort studies.
    Clin Exp Hypertens. 2024;46:2341631.
    

    >> Share

    
    
49. REN F, Yang M, Liu G, Qi Y, et al
    SIRT5-mediated PRKAA2 succinylation ameliorates apoptosis of human placental trophoblasts in hypertensive disorder complicating pregnancy.
    Clin Exp Hypertens. 2024;46:2358030.
    

    >> Share

    
    
50. XU W, Gao X, Luo H, Chen Y, et al
    FGF21 attenuates salt-sensitive hypertension via regulating HNF4alpha/ACE2 axis in the hypothalamic paraventricular nucleus of mice.
    Clin Exp Hypertens. 2024;46:2361671.
    

    >> Share

    
    
51. LIU S, Zhang H, Wu M, Zhou Z, et al
    Association between the triglyceride-glucose index and carotid artery plaque burden in patients with primary hypertension: A cross-sectional study.
    Clin Exp Hypertens. 2024;46:2383232.
    

    >> Share

    
    
52. YIN L, Zhang X, Zhang H, Li R, et al
    Analysis of the current status and associated risk factors of cognitive function in Tibetan hypertensive patients at various altitudes.
    Clin Exp Hypertens. 2024;46:2393331.
    

    >> Share

    
    
53. YANG L, Zhu X, Zhu J, Hu Z, et al
    Gestational diabetes causes hyperactivity of the sympathetic nervous system and hypertension in adult mice offspring.
    Clin Exp Hypertens. 2024;46:2402260.
    

    >> Share

    
    
54. MAO J, Zhang X, Wang C, Peng S, et al
    Irisin mitigates salt-sensitive hypertension via regulating renal AMPK-Rac1 pathway.
    Clin Exp Hypertens. 2024;46:2402258.
    

    >> Share

    
    December 2023
55. WANG Y, Xia M, Lu J, Wang T, et al
    TIP60 mediates stress-induced hypertension via promoting glutamate(dmPFC-)(to-)(vCA1) release.
    Clin Exp Hypertens. 2023;45:2259130.
    

    >> Share

    
    
56. CAI X, Song S, Hu J, Zhu Q, et al
    Body roundness index improves the predictive value of cardiovascular disease risk in hypertensive patients with obstructive sleep apnea: a cohort study.
    Clin Exp Hypertens. 2023;45:2259132.
    

    >> Share

    
    
57. WU W, Chen Y, Wu K, Zheng H, et al
    Accumulated exposure to high non-high-density lipoprotein cholesterol increases the risk of cardiovascular diseases in hypertensive individuals: An 11-year prospective cohort study.
    Clin Exp Hypertens. 2023;45:2264540.
    

    >> Share

    
    
58. HU S, Zhang Y, Qiu C, Li Y, et al
    RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling.
    Clin Exp Hypertens. 2023;45:2271186.
    

    >> Share

    
    
59. PANG J, Qian L, Che X, Lv P, et al
    TyG index is a predictor of all-cause mortality during the long-term follow-up in middle-aged and elderly with hypertension.
    Clin Exp Hypertens. 2023;45:2272581.
    

    >> Share

    
    
60. YU W, Zhang Q, Qiu Y, Chen H, et al
    CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells.
    Clin Exp Hypertens. 2023;45:2272062.
    

    >> Share

    
    
61. ZHOU X, Zhang L, Lin X, Chen X, et al
    Thrombospondin 2 is a novel biomarker of essential hypertension and associated with nocturnal Na(+) excretion and insulin resistance.
    Clin Exp Hypertens. 2023;45:2276029.
    

    >> Share

    
    
62. HUA R, Liu B, He W, Zhang H, et al
    Calcitriol reverses age-related hypertension via downregulating renal AP1/AT(1)R pathway through regulating mitochondrial function.
    Clin Exp Hypertens. 2023;45:2277653.
    

    >> Share

    
    
63. TANG L, Cai Q, Wang X, Li X, et al
    Canagliflozin ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting pulmonary arterial smooth muscle cell proliferation.
    Clin Exp Hypertens. 2023;45:2278205.
    

    >> Share

    
    
64. LIU H, Li Y, Li M, Xie L, et al
    Follistatin-like 1 protects endothelial function in the spontaneously hypertensive rat by inhibition of endoplasmic reticulum stress through AMPK-dependent mechanism.
    Clin Exp Hypertens. 2023;45:2277654.
    

    >> Share

    
    
65. TIAN X, Feng J, Chen S, Zhang Y, et al
    Baseline and longitudinal cardiovascular health using Life's Essential 8 metrics with the risk of incident hypertension.
    Clin Exp Hypertens. 2023;45:2271190.
    

    >> Share

    
    
66. YANG J, Jiang G, Huang L, Liu Z, et al
    The Long non-coding RNA MALAT1 functions as a competing endogenous RNA to regulate vascular remodeling by sponging miR-145-5p/HK2 in hypertension.
    Clin Exp Hypertens. 2023;45:2284658.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share